Latest Information Update: 05 Oct 2006
At a glance
- Originator Theramex SAM
- Mechanism of Action Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Menstruation disorders
Most Recent Events
- 05 Oct 2006 Discontinued - Phase-II for Menstruation disorders in Europe (PO)
- 10 Apr 2002 Phase-II clinical trials in Menstruation disorders in Europe (PO)